Three Cryptocurrencies to Hold in 2021

From Investorplace Media | Ad

In 2021, Dogecoin went up over 12,000%. SafeMoon went up more than 20,000%...

But if you missed those gains, there is still time to get in on the digital currency boom.

Luke Lango – InvestorPlace’s resident crypto expert – just released the names of 3 tokens every investor should own in a free report.

Click here to claim your copy today.

IMUX Insider Trading (Immunic)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.00%

Insider Buying (Last 12 Months): $69,960.00

Insider Selling (Last 12 Months): $0.00

Immunic Insider Trading History Chart

Immunic Share Price & Price History

^$9.15

▲ +0.35 (3.98%)

As of 07/28/2021 04:09 PM ET

Days: 30 | 90 | 365

Even Utah Is Falling in Love with Psychedelics

From Investing Trends | Ad

Nobody ever thinks of ultra-conservative Utah as a liberal stronghold. But one company there has already joined companies in California and Arizona in administering psychedelic treatments as a novel solution to depression. And that could mean the legal psychedelics market is poised to explode.

Here's how you could get in on the ground floor

Immunic Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/12/2021	Duane Nash	Chairman	Buy	4,000	$12.75	$51,000.00	14,032
8/10/2020	Glenn Whaley	Insider	Buy	1,000	$18.96	$18,960.00	1,000
7/21/2020	Daniel Vitt	CEO	Sell	6,300	$14.68	$92,484.00
7/21/2020	Manfred Groeppel	COO	Sell	5,650	$14.58	$82,377.00
12/4/2019	Duane Nash	Director	Sell	4,400	$6.96	$30,624.00	22,362

Insider Buying at Immunic?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Immunic and related companies.

SEC Filings (Institutional Ownership Changes) for Immunic (NASDAQ:IMUX)

42.78% of Immunic stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Immunic Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/18/2021	Millennium Management LLC	159,323	$2.54M	0.0%	-25.2%	0.733%
5/18/2021	Point72 Asset Management L.P.	433,047	$6.90M	0.0%	+111.8%	1.991%
5/18/2021	Verition Fund Management LLC	24,692	$0.39M	0.0%	-69.0%	0.114%
5/17/2021	Endurant Capital Management LP	131,796	$2.10M	0.5%	-4.9%	0.606%
5/17/2021	Schonfeld Strategic Advisors LLC	42,100	$0.67M	0.0%	+6.3%	0.194%
5/17/2021	Price T Rowe Associates Inc. MD	262,382	$4.18M	0.0%	-36.7%	1.206%
5/17/2021	Ameriprise Financial Inc.	21,675	$0.35M	0.0%	-23.0%	0.100%
5/17/2021	Nuveen Asset Management LLC	41,851	$0.67M	0.0%	-73.4%	0.192%
5/14/2021	Parkman Healthcare Partners LLC	401,218	$6.40M	1.5%	+9.4%	1.845%
5/14/2021	TD Asset Management Inc.	32,628	$0.52M	0.0%	+31.4%	0.150%
5/13/2021	Barclays PLC	4,698	$75K	0.0%	+469,700.0%	0.022%
5/12/2021	Northern Trust Corp	100,257	$1.60M	0.0%	-14.4%	0.461%
5/12/2021	Geode Capital Management LLC	164,430	$2.62M	0.0%	+7.9%	0.756%
5/11/2021	New York State Common Retirement Fund	3,500	$56K	0.0%	-52.7%	0.016%
5/10/2021	Otter Creek Advisors LLC	35,000	$0.56M	0.4%	N/A	0.161%
5/7/2021	BlackRock Inc.	734,792	$11.71M	0.0%	+2.2%	3.379%
5/7/2021	Alps Advisors Inc.	38,298	$0.61M	0.0%	+2.3%	0.176%
2/18/2021	Verition Fund Management LLC	79,664	$1.22M	0.0%	+78.4%	0.385%
2/17/2021	Jane Street Group LLC	31,967	$0.49M	0.0%	N/A	0.154%
2/16/2021	Squarepoint Ops LLC	41,642	$0.64M	0.0%	+72.1%	0.201%
2/16/2021	Endurant Capital Management LP	138,613	$2.12M	0.8%	+25.0%	0.669%
2/16/2021	Nuveen Asset Management LLC	157,086	$2.40M	0.0%	-4.9%	0.758%
2/16/2021	Price T Rowe Associates Inc. MD	414,479	$6.34M	0.0%	N/A	2.001%
2/12/2021	Federated Hermes Inc.	24,364	$0.37M	0.0%	+45,018.5%	0.118%
2/11/2021	Trexquant Investment LP	17,671	$0.27M	0.0%	+76.0%	0.085%
2/11/2021	Northern Trust Corp	117,143	$1.79M	0.0%	-4.2%	0.565%
2/11/2021	Citigroup Inc.	3,334	$51K	0.0%	+1,041.8%	0.016%
2/11/2021	Artal Group S.A.	700,000	$10.70M	0.2%	-12.5%	3.379%
2/10/2021	Renaissance Technologies LLC	13,400	$0.21M	0.0%	-62.1%	0.065%
2/9/2021	Wells Fargo & Company MN	25,848	$0.40M	0.0%	+29.6%	0.125%
2/9/2021	Bank of New York Mellon Corp	40,464	$0.62M	0.0%	+14.6%	0.195%
2/8/2021	New York State Common Retirement Fund	7,400	$0.11M	0.0%	+311.1%	0.036%
2/5/2021	BlackRock Inc.	719,121	$11M	0.0%	+43.5%	3.471%
1/25/2021	Golden Green Inc.	70,900	$1.08M	1.0%	N/A	0.342%
12/14/2020	Strs Ohio	7,100	$0.13M	0.0%	+688.9%	0.034%
11/19/2020	Schonfeld Strategic Advisors LLC	91,400	$1.70M	0.0%	+154.6%	0.441%
11/17/2020	California State Teachers Retirement System	8,426	$0.16M	0.0%	+62.6%	0.041%
11/17/2020	Schonfeld Strategic Advisors LLC	91,400	$1.70M	0.0%	+154.6%	0.441%
11/16/2020	Squarepoint Ops LLC	24,193	$0.45M	0.0%	N/A	0.117%
11/13/2020	Charles Schwab Investment Management Inc.	18,124	$0.34M	0.0%	N/A	0.121%
11/12/2020	Pathstone Family Office LLC	1,860	$35K	0.0%	N/A	0.012%
11/12/2020	JPMorgan Chase & Co.	2,076	$39K	0.0%	-29.3%	0.014%
11/12/2020	Massachusetts Financial Services Co. MA	12,093	$0.23M	0.0%	N/A	0.081%
11/10/2020	State Street Corp	70,625	$1.31M	0.0%	+111.7%	0.472%
11/6/2020	BlackRock Inc.	501,224	$9.31M	0.0%	+139.8%	3.349%
11/6/2020	Trexquant Investment LP	10,038	$0.19M	0.0%	N/A	0.067%
11/5/2020	New York State Common Retirement Fund	1,800	$33K	0.0%	-71.9%	0.012%
11/5/2020	Wells Fargo & Company MN	19,943	$0.37M	0.0%	+11.6%	0.133%
11/4/2020	American International Group Inc.	3,330	$62K	0.0%	+58.3%	0.022%
11/3/2020	Lindbrook Capital LLC	4,200	$78K	0.0%	N/A	0.028%
9/15/2020	Schonfeld Strategic Advisors LLC	35,900	$0.44M	0.0%	N/A	0.240%
8/25/2020	Nuveen Asset Management LLC	19,049	$0.23M	0.0%	N/A	0.127%
8/24/2020	FMR LLC	137,191	$1.66M	0.0%	N/A	0.916%
8/14/2020	Point72 Asset Management L.P.	175,000	$2.12M	0.0%	N/A	1.169%
8/14/2020	Verition Fund Management LLC	91,419	$1.11M	0.0%	+708.9%	0.611%
8/14/2020	Bank of America Corp DE	10,385	$0.13M	0.0%	+303.9%	0.069%
8/14/2020	Artal Group S.A.	600,000	$7.27M	0.2%	-4.8%	4.009%
8/14/2020	Sabby Management LLC	53,009	$0.64M	0.1%	N/A	0.354%
8/13/2020	FMR LLC	137,191	$1.66M	0.0%	N/A	0.917%
8/12/2020	American International Group Inc.	2,103	$25K	0.0%	N/A	0.014%
8/12/2020	Granite Point Capital Management L.P.	198,027	$2.40M	0.1%	N/A	1.323%
8/12/2020	Hudson Bay Capital Management LP	123,048	$1.49M	0.0%	N/A	0.822%
8/7/2020	New York State Common Retirement Fund	6,400	$78K	0.0%	N/A	0.043%
8/3/2020	Leap Investments LP	11,500	$0.14M	0.1%	N/A	0.077%
7/14/2020	International Biotechnology Trust PLC	123,000	$1.53M	0.5%	N/A	0.822%
5/14/2020	Wells Fargo & Company MN	10,814	$65K	0.0%	+78.9%	0.085%
5/1/2020	BlackRock Inc.	32,418	$0.20M	0.0%	-4.7%	0.294%
2/13/2020	Renaissance Technologies LLC	60,631	$0.59M	0.0%	+44.3%	0.599%
11/27/2019	Millennium Management LLC	11,937	$0.12M	0.0%	-99.7%	0.118%
8/14/2019	Vanguard Group Inc.	11,523	$0.13M	0.0%	N/A	1.088%
8/13/2019	Tower Research Capital LLC TRC	2,910	$33K	0.0%	N/A	0.275%
8/13/2019	BlackRock Inc.	12,601	$0.15M	0.0%	N/A	1.190%
8/13/2019	Omega Fund Management LLC	1,371,494	$15.73M	4.0%	N/A	129.386%
8/12/2019	Independent Advisor Alliance	70,057	$0.80M	0.1%	N/A	6.615%

Data available starting January 2016

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.

Today's Range

Now: $9.15

$8.75

$9.15

50 Day Range

MA: $12.49

$8.80

$14.77

52 Week Range

Now: $9.15

$8.64

$28.21

Volume

5,162 shs

Average Volume

216,360 shs

Market Capitalization

$240.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.04

Who are the company insiders with the largest holdings of Immunic?

Immunic's top insider shareholders include:

Duane Nash (Director)
Duane Nash (Chairman)
Glenn Whaley (Insider)
Daniel Vitt (CEO)
Manfred Groeppel (COO)

Three Cryptocurrencies to Hold in 2021

From Investorplace Media | Ad

Click here to claim your copy today.